Clinical Trial Update: RhD+ Blood Transfusion to Asian-type DEL Recipients [NA]

View source ↗

Summary

A completed clinical trial evaluating RhD-positive blood transfusion in Asian-type DEL recipients; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Transfusion-related Disorders
• Rhesus Isoimmunization Due to Anti-d

Snippet

Sponsor: Guangzhou Blood Center | Conditions: Blood Transfusion, Rhesus Isoimmunisation Due to Anti-D | NA | Status: COMPLETED | Results posted: 2024-03-21